68 related articles for article (PubMed ID: 16539034)
21. Studies of the photooxidant properties of antibacterial fluoroquinolones and their naphthalene derivatives.
Vargas F; Zoltan T; Ramirez AH; Cordero T; Chavez V; Izzo C; López V; Cárdenas YM; Fernández A; Hincapie L; Fuentes A
Pharmazie; 2009 Feb; 64(2):116-22. PubMed ID: 19320285
[TBL] [Abstract][Full Text] [Related]
22. Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
Nozaki-Renard J; Iino T; Sato Y; Marumoto Y; Ohta G; Furusawa M
Cell Struct Funct; 1990 Oct; 15(5):295-9. PubMed ID: 2085844
[TBL] [Abstract][Full Text] [Related]
23. 4-quinolones inhibit biotransformation of caffeine.
Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
[TBL] [Abstract][Full Text] [Related]
24. Vibrational spectroscopic characterization of fluoroquinolones.
Neugebauer U; Szeghalmi A; Schmitt M; Kiefer W; Popp J; Holzgrabe U
Spectrochim Acta A Mol Biomol Spectrosc; 2005 May; 61(7):1505-17. PubMed ID: 15820884
[TBL] [Abstract][Full Text] [Related]
25. Use of a fluorescent stain for evaluating in vitro infection with Leishmania panamensis.
Pérez-Cordero JJ; Sánchez-Suárez J; Delgado G
Exp Parasitol; 2011 Sep; 129(1):31-5. PubMed ID: 21684278
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
Barnett G; Segura J; de la Torre R; Carbó M
Eur J Clin Pharmacol; 1990; 39(1):63-9. PubMed ID: 2177401
[TBL] [Abstract][Full Text] [Related]
27. [Styrylquinolines-type synthetic compounds with leishmanicidal and cytotoxic activities].
Sánchez EL; Santafé GG; Torres OL; Muñoz DL; Robledo SM
Biomedica; 2014; 34(4):605-11. PubMed ID: 25504250
[TBL] [Abstract][Full Text] [Related]
28. Permissiveness of human monocytes and monocyte-derived macrophages to infection by promastigotes of Leishmania (Viannia) panamensis.
Bosque F; Milon G; Valderrama L; Saravia NG
J Parasitol; 1998 Dec; 84(6):1250-6. PubMed ID: 9920322
[TBL] [Abstract][Full Text] [Related]
29. Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents.
Tan YM; Li D; Li FF; Fawad Ansari M; Fang B; Zhou CH
Bioorg Med Chem Lett; 2022 Oct; 73():128885. PubMed ID: 35835379
[TBL] [Abstract][Full Text] [Related]
30. Photo-induced interaction of antibacterial quinolones with human serum albumin.
Vargas F; Rivas C; Díaz Y; Fernández A
Toxicol Mech Methods; 2003; 13(3):221-6. PubMed ID: 20021162
[TBL] [Abstract][Full Text] [Related]
31. Leishmanicidal activity of aliphatic and aromatic lactones: correlation structure-activity.
Castaño M; Cardona W; Quiñones W; Robledo S; Echeverri F
Molecules; 2009 Jul; 14(7):2491-500. PubMed ID: 19633618
[TBL] [Abstract][Full Text] [Related]
32. Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice.
Hori S; Kizu J; Kawamura M
J Infect Chemother; 2006 Apr; 12(2):109-11. PubMed ID: 16648952
[TBL] [Abstract][Full Text] [Related]
33. Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response.
Ramírez C; Díaz-Toro Y; Tellez J; Castilho TM; Rojas R; Ettinger NA; Tikhonova I; Alexander ND; Valderrama L; Hager J; Wilson ME; Lin A; Zhao H; Saravia NG; McMahon-Pratt D
PLoS Negl Trop Dis; 2012; 6(10):e1866. PubMed ID: 23145196
[TBL] [Abstract][Full Text] [Related]
34. Novel action of quinolones on osteoclast-like cells.
Fukuishi N; Matsui N; Kanoh R; Akagi M
J Toxicol Sci; 1999 Dec; 24(5):383-91. PubMed ID: 10656159
[TBL] [Abstract][Full Text] [Related]
35. The Akt-like kinase of Leishmania panamensis: As a new molecular target for drug discovery.
Tirado-Duarte D; Marín-Villa M; Ochoa R; Blandón-Fuentes G; Soares MJ; Robledo SM; Varela-Miranda RE
Acta Trop; 2018 Jan; 177():171-178. PubMed ID: 29037519
[TBL] [Abstract][Full Text] [Related]
36. The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives.
Jałbrzykowska K; Chrzanowska A; Roszkowski P; Struga M
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804828
[TBL] [Abstract][Full Text] [Related]
37. Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis.
Romero I; Téllez J; Suárez Y; Cardona M; Figueroa R; Zelazny A; Gore Saravia N
PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20856851
[TBL] [Abstract][Full Text] [Related]
38. Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones.
Ruiz J
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541707
[TBL] [Abstract][Full Text] [Related]
39. Potency and Preclinical Evidence of Synergy of Oral Azole Drugs and Miltefosine in an
Fernández OL; Rosales-Chilama M; Quintero N; Travi BL; Wetzel DM; Gómez MA; Saravia NG
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0142521. PubMed ID: 34694879
[TBL] [Abstract][Full Text] [Related]
40. Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?
Dalhoff A
Infection; 2021 Feb; 49(1):29-56. PubMed ID: 33367978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
